| Literature DB >> 35965628 |
Tianzhao Han1, Yunlei Deng1, Dayong Quan1, Dan Wu1, Shuxin Xiao1, Rong Gong1.
Abstract
Protein malnutrition is a well-described complication of peritoneal dialysis (PD), a standard mode of treatment for end-stage renal disease (ESRD), and contributes to morbidity, treatment failure, and mortality. To assess the usefulness of WeChat-based education for ensuring optimal protein intake through the consumption of egg white protein, 140 young and middle-aged patients undergoing PD are assigned to either the intervention group or the control group. The results show that reinforcing comprehensive PD education using WeChat can improve nutritional parameters, clinical parameters, and quality of life.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35965628 PMCID: PMC9357735 DOI: 10.1155/2022/5651992
Source DB: PubMed Journal: Contrast Media Mol Imaging ISSN: 1555-4309 Impact factor: 3.009
Figure 1Flowchart of the study design.
Figure 2Route of approach for comprehensive PD education on the WeChat platform.
Characteristics of the two groups at enrolment.
| Group | Age (years) | Sex ( | Diabetes (%) | BMI (kg/m2) | Education ( | ||
| Lower than primary school | High school | College degree or above | |||||
| IG | 46.34 ± 13.86 | 34 (57.63%) | 14 (23.73%) | 22.95 ± 3.35 | 6 (10.17%) | 37 (62.71%) | 16 (27.12%) |
| CG | 48.09 ± 13.40 | 34 (62.96%) | 14 (25.93%) | 23.51 ± 3.73 | 5 (9.26%) | 27 (50%) | 22 (40.74%) |
|
| −0.68 | 0.34 | 0.07 | −0.83 | 2.38 | ||
|
| 0.50 | 0.56 | 0.79 | 0.41 | 0.30 | ||
|
| |||||||
| Group | PD duration (months) | Dialysate volume ( | Ketoacid (g/d) | Calcium carbonate (%) | KDTA score | SF-36 score | |
| IG | 14 (3–27) | 7.31 ± 1.39 | 5.19 ± 3.40 | 20 (33.89%) | 59.74 ± 5.77 | 52.78 ± 7.46 | |
| CG | 9 (5–16) | 7.14 ± 1.31 | 5.78 ± 3.50 | 17 (31.48%) | 58.85 ± 5.49 | 50.76 ± 7.46 | |
| t/ | 1.19 | 0.63 | −0.91 | 0.08 | 0.83 | 1.48 | |
|
| 0.24 | 0.53 | 0.37 | 0.78 | 0.41 | 0.14 | |
Dietary parameters from the baseline to the end of the study.
| Dietary parameters | Group | 0 months |
| 6 months |
| 12 months |
| Time × group, |
|---|---|---|---|---|---|---|---|---|
| DPI (g·kg−1·d−1) | IG | 0.95 ± 0.18 | 0.59 | 1.05 ± 0.22 | 0.02 | 1.13 ± 0.31 | <0.01 | 0.008 (0.13) |
| CG | 0.93 ± 0.25 | 0.94 ± 0.28 | 0.98 ± 0.30 | |||||
|
| ||||||||
| EWPI (g·kg−1·d−1) | IG | 0.05 ± 0.04 | 0.56 | 0.12 ± 0.05 | <0.01 | 0.16 ± 0.08 | <0.01 | 0.000 (0.09) |
| CG | 0.04 ± 0.04 | 0.05 ± 0.05 | 0.06 ± 0.05 | |||||
|
| ||||||||
| HBVPI (g·kg−1·d−1) | IG | 0.46 ± 0.13 | 0.74 | 0.61 ± 0.21 | 0.01 | 0.69 ± 0.23 | <0.01 | 0.001 (0.14) |
| CG | 0.45 ± 0.19 | 0.51 ± 0.23 | 0.53 ± 0.23 | |||||
|
| ||||||||
|
| IG | 47.77 ± 6.45 | 0.50 | 56.45 ± 8.85 | <0.01 | 59.73 ± 6.84 | <0.01 | 0.0003 (5.98) |
| CG | 46.82 ± 8.39 | 51.95 ± 8.52 | 52.80 ± 8.51 | |||||
|
| ||||||||
|
| IG | 10.13 ± 6.80 | 0.57 | 18.43 + 5.71 | <0.01 | 22.34 ± 7.15 | <0.01 | 0.000 (11.39) |
| CG | 9.38 ± 7.32 | 9.82 + 7.62 | 10.19 ± 7.51 | |||||
|
| ||||||||
| DEI (kJ·kg−1·d−1) | IG | 110.21 ± 13.74 | 0.55 | 111.97 ± 22.35 | 0.42 | 117.74 ± 19.76 | 0.11 | 0.140 (4.47) |
| CG | 108.31 ± 19.81 | 108.52 ± 22.40 | 111.38 ± 21.75 | |||||
|
| ||||||||
| TEI (kJ·kg−1·d−1) | IG | 132.36 ± 16.00 | 0.54 | 135.90 ± 22.50 | 0.34 | 139.09 ± 21.18 | 0.41 | 0.422 (2.52) |
| CG | 130.33 ± 18.93 | 131.59 ± 25.44 | 134.54 ± 24.89 | |||||
Change in laboratory parameters from the baseline to the end of the study.
| Group | 0 months |
| 6 months |
| 12 months |
| Time × group, | |
|---|---|---|---|---|---|---|---|---|
| Albumin (g/L) | IG | 36.96 ± 2.87 | 0.32 | 38.89 ± 4.00 | 0.03 | 39.62 ± 3.85 | 0.004 | 0.049 (1.50) |
| CG | 36.22 ± 4.77 | 37.02 ± 4.78 | 37.39 + 3.51 | |||||
|
| ||||||||
| Hemoglobin (g/L) | IG | 102.90 ± 20.21 | 0.88 | 101.73 ± 18.24 | 0.34 | 104.10 ± 18.81 | 0.94 | 0.77 (0.84) |
| CG | 102.26 ± 22.45 | 105.59 ± 17.96 | 103.85 ± 17.10 | |||||
|
| ||||||||
| P (mmol/L) | IG | 1.63 ± 0.49 | 0.45 | 1.70 ± 0.50 | 0.50 | 1.72 ± 0.38 | 0.58 | 0.44 (0.06) |
| CG | 1.56 ± 0.61 | 1.62 ± 0.48 | 1.67 ± 0.48 | |||||
|
| ||||||||
| iPTH (pg/ml, | IG | 326.00 (234.80, 481.25) | 0.17 | 350.50 (222.20, 627.10) | 0.07 | 360.20 (217.25, 684.15) | 0.12 | 0.48 (34.63) |
| CG | 258.60 (138.10, 435.43) | 251.60 (133.55, 395.10) | 270.10 (100.69, 514.58) | |||||
|
| ||||||||
| Total cholesterol (mmol/l) | IG | 4.66 ± 1.1 | 0.82 | 4.68 ± 1.29 | 0.60 | 4.85 ± 1.22 | 0.85 | 0.89 (−0.03) |
| CG | 4.72 ± 1.10 | 4.81 ± 0.97 | 4.90 ± 0.93 | |||||
|
| ||||||||
| Triglyceride (mmol/l) | IG | 1.93 ± 1.10 | 0.76 | 1.96 ± 1.25 | 0.40 | 1.97 + 1.12 | 0.04 | 0.07 (−0.50) |
| CG | 1.85 ± 1.23 | 2.15 ± 1.21 | 2.38 ± 1.24 | |||||
|
| ||||||||
|
| IG | 2.09 ± 0.49 | 0.30 | 1.91 ± 0.45 | 0.56 | 1.90 ± 0.32 | 0.03 | 0.61 (0.05) |
| CG | 1.99 ± 0.50 | 1.86 ± 0.46 | 1.76 ± 0.39 | |||||
|
| ||||||||
| Ccr ( | IG | 67.21 ± 20.08 | 0.55 | 59.28 ± 15.79 | 0.93 | 59.04 ± 13.17 | 0.01 | 0.047 (5.12) |
| CG | 64.65 ± 25.53 | 54.61 ± 24.77 | 52.37 ± 14.09 | |||||
|
| ||||||||
| RRF (ml/min, | IG | 2.53 (0.73, 5.36) | 0.18 | 2.29 (0.49, 4.23) | 0.79 | 2.080 (0.00, 4.87) | 0.70 | 0.01 (0.89) |
| CG | 2.72 (0.56, 6.32) | 2.06 (0.34, 4.17) | 1.58 (0.34, 3.33) | |||||
|
| ||||||||
| nPCR (g·kg−1·d−1) | IG | 0.89 ± 0.20 | 0.46 | 0.966 ± 0.185 | 0.09 | 1.04 ± 0.19 | 0.002 | 0.049 (0.08) |
| CG | 0.86 ± 0.19 | 0.881 ± 0.322 | 0.93 ± 0.18 | |||||
Figure 3Correlation of serum albumin levels with the ratio of egg white protein intake to high biological value protein intake.
Comparison of peritonitis rate, rehospitalization rate, dietary adherence, and quality of life between the intervention and control groups at the end of the study.
| Group | Peritonitis rate (1 episode per patient-year) | Rehospitalization rate ( | Dietary adherence ( | KDTA score | SF-36 score |
|---|---|---|---|---|---|
| IG | 0.169 | 20 (33.9%) | 37 (62.7%) | 65.44 ± 5.04 | 59.80 ± 7.46 |
| CG | 0.333 | 28 (51.9%) | 15 (27.8%) | 61.92 ± 7.56 | 55.82 ± 5.43 |
| OR/ | 0.408 | 0.476 | 4.3727 | −2.94 | −3.25 |
|
| 0.047 | 0.055 | 0.0003 | 0.004 | 0.001 |